drugset / Trial / NCT00401284

Efficacy Study of EVT 201 in the Treatment of Elderly Patients With Daytime Sleepiness

NCT00401284 ↗

Phase 2 Completed 135 enrolled Evotec Neurosciences GmbH
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine whether a compound known as EVT 201 is effective in treating elderly patients diagnosed with primary insomnia who also have moderate daytime sleepiness.

Timeline

Start
2006-11
Primary completion
—
Completion
2007-07

Drugs

EvaluationDrugModalityDoseRoute
Subject DIMDAZENIL Small molecule — —